Quick Answer
Cocrystal Pharma, Inc. reported Total Assets of $9.71 million for fiscal year 2025.
Cocrystal Pharma, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $9.71M | -27.8% |
| 2024 | $13.46M | -57.0% |
| 2023 | $31.26M | -23.5% |
| 2022 | $40.84M | -48.6% |
| 2021 | $79.39M | +46.4% |
| 2020 | $54.24M | +90.1% |
| 2019 | $28.53M | -58.4% |
| 2018 | $68.56M | -43.5% |
| 2017 | $121.43M | -2.8% |
| 2016 | $124.88M | -44.3% |
| 2015 | $224.23M | -13.5% |
| 2014 | $259.28M | +15510.1% |
| 2013 | $1.66M | -77.1% |
| 2012 | $7.24M | -4.1% |
| 2011 | $7.55M | +0.2% |
| 2010 | $7.53M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $10.45M | -35.6% | +22.8% |
| June 30, 2025 | $8.51M | -60.6% | -20.2% |
| March 31, 2025 | $10.66M | -59.8% | -20.8% |
| December 31, 2024 | $13.46M | -57.0% | -17.1% |
| September 30, 2024 | $16.23M | -50.2% | -24.8% |
| June 30, 2024 | $21.57M | -40.5% | -18.7% |
| March 31, 2024 | $26.55M | -29.8% | -15.1% |
| December 31, 2023 | $31.26M | -23.5% | -4.2% |
- Cocrystal Pharma, Inc. showed a decrease of -27.8% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Cocrystal Pharma, Inc.’s total assets has grown by 28.9% (from $7.53 million to $9.71 million).
- The most recent figure is from Cocrystal Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: